← Retour au Screener

Sector: Santé
Open in Terminal → SOON.SWLive chart · Key metrics · News · Smart money

Sonova Holding

SOON.SW Large Cap

Healthcare · Medical Devices

Mis à jour: Jun 18, 2026, 22:21 UTC

196,40 CHF
-0.71% aujourd'hui
52W: 163,00 CHF – 248,00 CHF
52W Low: 163,00 CHF Position: 39.3% 52W High: 248,00 CHF

Price Chart

Indicateurs clés

P/E Ratio
21.8x
Cours/Bénéfice
Forward P/E
16.81x
P/E prévisionnel
P/S Ratio
3.24x
Cours/Ventes
EV/EBITDA
14.86x
Valeur d'entreprise/EBITDA
Rend. dividende
Rendement annuel du dividende
Cap. boursière
10,2 Md €
Capitalisation boursière
Croissance du CA
Croissance du CA sur un an
Marge bénéficiaire
11.94%
Marge nette
ROE
20.52%
Rentabilité des capitaux propres
Beta
1.07
Sensibilité au marché
Positions vendeuses
% du flottant vendu à découvert
Volume moyen
179,527
Volume quotidien moyen

Valuation Analysis

Signal
Fair
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
Conserver
19 analysts
Avg. Price Target
216,51 CHF
+10.24% upside
Target Range
169,00 CHF – 300,00 CHF

About the Company

Sector: Healthcare Industry: Medical Devices Country: Switzerland Employees: 18,570 Exchange: EBS

Sonova Holding en bref

Sonova Holding (SOON.SW) is currently trading at 196,40 CHF with a market capitalization of 10,2 Md €. The trailing P/E ratio stands at 21.8x, with a forward P/E of 16.81x. The 52-week range spans from 163,00 CHF to 248,00 CHF ; the current price is 20.8% below the yearly high.

💰 Dividende

Sonova Holding currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

19 analystes évaluent Sonova Holding (SOON.SW) au consensus : Conserver. L'objectif de cours moyen est de 216,51 CHF , soit un potentiel de +10.24% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 169,00 CHF à 300,00 CHF .

Sonova Holding : la thèse d'investissement en détail

Sonova Holding (SOON.SW) operates in the Healthcare — specifically Medical Devices — and is headquartered in Switzerland. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

With a gross margin near 73.72%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns.

Valorisation en contexte

The PEG ratio at 1.16 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.

À surveiller

  • The forward P/E of 16.81x is meaningfully below the trailing 21.8x — analysts expect earnings to step up; the next earnings release is the test.

Thèse d'investissement : forces et faiblesses

Points forts
  • Rentabilité élevée des capitaux propres (20.52% ROE)
  • Marge brute élevée de 73.72% — signe d'un pouvoir de fixation des prix
  • Free cash flow positif
Points faibles

Aucun signal d'alerte significatif dans les indicateurs actuels.

Aperçu technique

MM 50 jours
190,59 CHF
+3.05% vs. cours
MM 200 jours
204,07 CHF
-3.76% vs. cours
Sous le plus haut 52s
−20.8%
248,00 CHF
Au-dessus du plus bas 52s
+20.5%
163,00 CHF

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

Risque de marché (Bêta)
1.07 · Proche du marché
Évolue plus que le marché global
Dette/Capitaux propres
64.94 · Modéré
Dette totale / capitaux propres

The data points to market-like volatility.

Trading Data

50-Day MA: 190,59 CHF
200-Day MA: 204,07 CHF
Volume: 124,155
Avg. Volume: 179,527
Short Ratio:
P/B Ratio: 4.46x
Debt/Equity: 64.94x
Free Cash Flow: 302 M €

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy Sonova Holding?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut